Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

Márton Jani1, Csilla Ambrus, Rémi Magnan

  • 1Solvo Biotechnology, Budaörs, Szeged, Hungary.

Archives of Toxicology
|April 30, 2014
PubMed

Insights

Breast cancer resistance protein (BCRP) is crucial for drug resistance and pharmacokinetics. New research clarifies its physiological roles and interactions using advanced methods, offering insights into species differences.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Genetics

Background:

  • Breast cancer resistance protein (BCRP) is an efflux transporter linked to multidrug resistance.
  • Its physiological significance was previously uncertain due to a lack of clear phenotypes in genetically modified models.
  • Endogenous substrates for BCRP are known, but its broader physiological role remained debated.

Purpose of the Study:

  • To summarize current knowledge on BCRP transporter function at molecular, tissue, and systemic levels.
  • To explore BCRP's role in both physiological processes and disease states.
  • To review common experimental methods for identifying BCRP substrates and inhibitors.

Main Methods:

  • High-performance genetic analyses to investigate BCRP relevance.
  • Fine-resolution tissue expression data analysis.
  • Quantitative proteomics for absolute interaction frameworks.
  • Review of experimental procedures for substrate and inhibitor identification.

Main Results:

  • BCRP's role in drug resistance and pharmacokinetics is well-established.
  • Advanced genetic and proteomic analyses reveal unexpected physiological relevance.
  • Quantitative proteomics provides frameworks for modeling interactions and understanding species differences.

Conclusions:

  • BCRP plays a significant role in physiology and disease beyond drug resistance.
  • Modern analytical techniques are crucial for fully understanding BCRP's complex functions.
  • Further research using these methods will enhance insights into interindividual and species variations in BCRP activity.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
5.7K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.7K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
388
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
398